COMBIGENE
CombiGene provides patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies. CombiGene’s business concept is to develop effective gene therapies for severe life-altering diseases where adequate treatment is currently lacking. CombiGene is developing a breakthrough therapy with the potential to dramatically improve the quality of life for a group of epilepsy patients for whom there is currently no effective treatment. CombiGene uses an ... adeno-associated viral vector (AAV) to administer a combination of neuropeptide Y (NPY) and its receptor Y2 directly to the part of the brain where the epileptic seizure begins. The most important preclinical effect studies have been concluded with positive results and the next step will be the compulsory safety studies. Given a positive outcome from the safety studies and successful GMP production of CG01, studies in humans can begin.
COMBIGENE
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.combigene.com
Total Employee:
1+
Status:
Active
Total Funding:
3.3 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Employees Featured
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Grant - CombiGene
Official Site Inspections
http://www.combigene.com Semrush global rank: 7.37 M Semrush visits lastest month: 515
Unable to get host informations!!!
More informations about "CombiGene"
CombiGene - Crunchbase Company Profile & Funding
CombiGene provides patients affected by severe life-altering diseases …See details»
CombiGene - LinkedIn
CombiGene | 1,997 followers on LinkedIn. CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment …See details»
CombiGene AB - VentureRadar
"CombiGene is a gene therapy company focused on developing treatments for challenging diseases lacking effective solutions. Its approach includes advancing drug candidates through …See details»
CombiGene Company Profile - Office Locations, Competitors
CombiGene has 5 employees at their 1 location and kr326 k in annual revenue in FY 2024. See insights on CombiGene including office locations, competitors, revenue, financials, executives, …See details»
The Board of Directors of CombiGene has received proposals from …
Oct 31, 2024 The Board of Directors will issue a notice to convene the EGM in a separate press release. This information is information that CombiGene is obliged to make public pursuant to …See details»
Combigene AB: Shareholders Board Members Managers and …
Combigene AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company specializes in development of treatments for neurological disorders. …See details»
CombiGene AB: Governance, Directors and Executives
Find the composition of the Board of Directors of CombiGene AB (Deutsche Boerse AG Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»
CCRM Nordic Announces Transfer of CombiGene AB’s Minority …
Feb 27, 2025 CCRM Nordic today announced that CombiGene AB has transferred its minority ownership stake in CCRM Nordic as part of CombiGene’s ongoing strategic restructuring. In …See details»
CombiGene AB (publ) publishes annual report for 2022
Apr 26, 2023 CombiGene announces that the annual report now is available on the Company´s homepage, www.combigene.com, and as an attachment to this press release. Contacts Jan …See details»
CombiGene - Biotechnology, Health and Wellness Company …
Want to explore more about CombiGene? Join now to unlock strategic insights, discover similar ventures, and explore exclusive company data — all powered by AI-driven analysis.See details»
☑️CombiGene — Consulting Organization from
CombiGene — Consulting Organization from Sweden, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Laboratory & Measurement, Science & Innovation sectorsSee details»
CombiGene - Financial Details - Crunchbase
CombiGene provides patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies.See details»
CombiGene strives for a broader pipeline - BioStock
Apr 21, 2022 CombiGene in-licensed CGT2 in 2019 from Lipigon Pharmaceuticals with the aim of developing a gene therapy treatment for the rare metabolic disease partial lipodystrophy. In …See details»
CombiGene launches new website - CombiGene
CombiGene’s business concept is to develop effective gene therapies for severe life-altering diseases where adequate treatment is currently lacking. Development assets are sourced from …See details»
CombiGene AB - Life-Sciences-Europe.com
CombiGene’s vision is to provide patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies. CombiGene’s business concept is to …See details»
CombiGene is very well positioned for continued success
I would also like to thank Jan and the entire team for the great introduction to CombiGene that I have received during my time as the company’s Chief Operating Officer. It is with great …See details»
CombiGene - Profiles & Contacts - Crunchbase
CombiGene provides patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies.See details»
CombiGene appoints new Chief Scientific Officer
May 27, 2024 CombiGene AB (publ) (“CombiGene”, the “Company”) announces today that Annika Ericsson, current Director Preclinical Development, will take over the role of Chief …See details»
CombiGene at the BIO International Convention in San Diego, USA
At the beginning of June, Jan Nilsson, former CEO and now Senior Advisor at CombiGene, together with Zyneyro’s CEO Peter Horn Møller and Scientific Advisor Kenneth Lindegaard …See details»
Annual General Meeting 2025 - CombiGene
Annual General Meeting 2025 - CombiGeneAnnual General Meeting 2025See details»